Scientific News Boston Scientific Corporation Bsx Surged On Excitement Over The Launch Of Its Ablation System
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Corporation Bsx Surged On Excitement Over The Launch Of Its Ablation System is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific: Q3 Earnings Snapshot
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Boston Scientific Corp. (BSX) on Wednesday reported third-quarter profit of $755 million. On a per-share basis, the Marlborough, Massachusetts-based ... Read More
Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript
Good morning, and welcome to the Boston Scientific Third Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ... Read More
Boston Scientific Corporation (BSX): A Bull Case Theory
We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BSX. Boston Scientific Corporation (BSX)'s ... Read More
Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst
On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion. The medical technology giant reported ... Read More
Boston Scientific (BSX) Fell Amid Rising Competition
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional ... Read More
Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth
Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion on Wednesday, beating the consensus estimate of $4.97 billion. The medical technology giant reported ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus